BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12920858)

  • 1. Characterization of a novel 99mTc-carbonyl complex as a functional probe of MDR1 P-glycoprotein transport activity.
    Dyszlewski M; Blake HM; Dahlheimer JL; Pica CM; Piwnica-Worms D
    Mol Imaging; 2002; 1(1):24-35. PubMed ID: 12920858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin.
    Chen WS; Luker KE; Dahlheimer JL; Pica CM; Luker GD; Piwnica-Worms D
    Biochem Pharmacol; 2000 Aug; 60(3):413-26. PubMed ID: 10856437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein.
    Crankshaw CL; Marmion M; Luker GD; Rao V; Dahlheimer J; Burleigh BD; Webb E; Deutsch KF; Piwnica-Worms D
    J Nucl Med; 1998 Jan; 39(1):77-86. PubMed ID: 9443741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier.
    Luker GD; Rao VV; Crankshaw CL; Dahlheimer J; Piwnica-Worms D
    Biochemistry; 1997 Nov; 36(46):14218-27. PubMed ID: 9369495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging multidrug resistance P-glycoprotein transport function using microPET with technetium-94m-sestamibi.
    Bigott HM; Prior JL; Piwnica-Worms DR; Welch MJ
    Mol Imaging; 2005; 4(1):30-9. PubMed ID: 15967124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.
    Moretti JL; Duran Cordobes M; Starzec A; de Beco V; Vergote J; Benazzouz F; Boissier B; Cohen H; Safi N; Piperno-Neumann S; Kouyoumdjian JC
    J Nucl Med; 1998 Jul; 39(7):1214-8. PubMed ID: 9669397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein versus MRP1 on transport kinetics of cationic lipophilic substrates: a comparative study using [99mTc]sestamibi and [99mTc]tetrofosmin.
    Gomes CM; Abrunhosa AJ; Pauwels EK; Botelho MF
    Cancer Biother Radiopharm; 2009 Apr; 24(2):215-27. PubMed ID: 19409044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a 67Ga/68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier.
    Sharma V; Prior JL; Belinsky MG; Kruh GD; Piwnica-Worms D
    J Nucl Med; 2005 Feb; 46(2):354-64. PubMed ID: 15695797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, molecular structure, and validation of metalloprobes for assessment of MDR1 P-glycoprotein-mediated functional transport.
    Sivapackiam J; Harpstrite SE; Prior JL; Gu H; Rath NP; Sharma V
    Dalton Trans; 2010 Jul; 39(25):5842-50. PubMed ID: 20505882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET?
    Yokogami K; Kawano H; Moriyama T; Uehara H; Sameshima T; Oku T; Goya T; Wakisaka S; Nagamachi S; Jinnouchi S; Tamura S
    Eur J Nucl Med; 1998 Apr; 25(4):401-9. PubMed ID: 9553170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of MS-209, a novel multidrug-resistance-reversing agent, in tumour-bearing mice by technetium-99m-MIBI imaging.
    Tatsumi M; Tsuruo T; Nishimura T
    Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):288-94. PubMed ID: 12002701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation.
    Piwnica-Worms D; Rao VV; Kronauge JF; Croop JM
    Biochemistry; 1995 Sep; 34(38):12210-20. PubMed ID: 7547962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line.
    Utsunomiya K; Ballinger JR; Piquette-Miller M; Rauth AM; Tang W; Su ZF; Ichise M
    Eur J Nucl Med; 2000 Dec; 27(12):1786-92. PubMed ID: 11189941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.
    Burak Z; Ersoy O; Moretti JL; Erinç R; Ozcan Z; Dirlik A; Sabah D; Basdemir G
    Eur J Nucl Med; 2001 Sep; 28(9):1341-50. PubMed ID: 11585293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel areneisonitrile Tc complex inhibits the transport activity of MDR P-glycoprotein.
    Rao VV; Herman LW; Kronauge JF; Piwnica-Worms D
    Nucl Med Biol; 1998 Apr; 25(3):225-32. PubMed ID: 9620627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes?
    Ak I; Gülbaş Z; Ocak S; Kaya E; Alataş F; Vardareli E; Metintaş M
    J Comput Assist Tomogr; 2007; 31(5):795-9. PubMed ID: 17895794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Efflux Transporter Affinity and Metabolism of
    Kobayashi M; Tsujiuchi T; Okui Y; Mizutani A; Nishi K; Nakanishi T; Nishii R; Fukuchi K; Tamai I; Kawai K
    Pharm Res; 2018 Nov; 36(1):18. PubMed ID: 30498970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
    Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes.
    Vergote J; Moretti JL; de Vries EG; Garnier-Suillerot A
    Eur J Biochem; 1998 Feb; 252(1):140-6. PubMed ID: 9523723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDR1 P-glycoprotein reduces influx of substrates without affecting membrane potential.
    Luker GD; Flagg TP; Sha Q; Luker KE; Pica CM; Nichols CG; Piwnica-Worms D
    J Biol Chem; 2001 Dec; 276(52):49053-60. PubMed ID: 11598111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.